Sign In

Login

Password

Forgot Password ? Sign Up

TMPRSS2 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "TMPRSS2" in Korean language version.

Last modified:

Ref.Un. Ref.Website
Global rank Korean rank
2020doi.org
2nd place
3rd place
1717nih.gov
5th place
4th place
62ensembl.org
630th place
323rd place
11archive.org
6th place
5th place

archive.org (Global: 6th place; Korean: 5th place)

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

  • B. Knudsen, J. Lucas, P. Nelson: Serine Proteases (Type II) Spanning the Plasma Membrane. In: M. Schwab (Hrsg.): Encyclopedia of Cancer. Springer, Berlin, Heidelberg, 2011. doi:10.1007/978-3-642-16483-5_5257
  • Jean Kaoru Millet; Gary R. Whittaker. 《Host cell proteases: critical determinants of coronavirus tropism and pathogenesis》. doi:10.1016/j.virusres.2014.11.021.
  • A. Shulla, T. Heald-Sargent, G. Subramanya, J. Zhao, S. Perlman, T. Gallagher: A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. In: Journal of Virology. Band 85, Nummer 2, Januar 2011, S. 873–882, doi:10.1128/JVI.02062-10, PMID 21068237, PMC 3020023.
  • Shirato K, Kanou K, Kawase M, Matsuyama S.: "Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry." In: J Virol. Dec 2016, doi:10.1128/JVI.01387-16, PMID 27733646 .
  • A. Zumla, J. F. Chan, E. I. Azhar, D. S. Hui, K. Y. Yuen: Coronaviruses - drug discovery and therapeutic options. In: Nature reviews. Drug discovery. Band 15, Nummer 5, 05 2016, S. 327–347, doi:10.1038/nrd.2015.37, PMID 26868298 (Review).
  • J. K. Sai, M. Suyama, Y. Kubokawa, Y. Matsumura, K. Inami, S. Watanabe: Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease. In: Journal of gastroenterology. Band 45, Nummer 3, März 2010, S. 335–341, doi:10.1007/s00535-009-0148-1, PMID 19876587.
  • R. Talukdar, R. K. Tandon: Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. In: Journal of gastroenterology and hepatology. Band 23, Nummer 1, Januar 2008, S. 34–41, doi:10.1111/j.1440-1746.2007.05206.x, PMID 17995943 (Review).
  • A. V. Ovcharenko, O. P. Zhirnov: Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. In: Antiviral research. Band 23, Nummer 2, Februar 1994, S. 107–118, doi:10.1016/0166-3542(94)90038-8, PMID 7511880.
  • A. Shulla, T. Heald-Sargent, G. Subramanya, J. Zhao, S. Perlman, T. Gallagher: A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. In: Journal of Virology. Band 85, Nummer 2, Januar 2011, S. 873–882, doi:10.1128/JVI.02062-10, PMID 21068237, PMC 3020023.
  • Chan J, Lau S, To K, Cheng V, Woo P, Yuen KY. 《Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease》. doi:10.1128/CMR.00102-14. 밴쿠버 양식 오류 (도움말)
  • M. Yamamoto, S. Matsuyama, X. Li, M. Takeda, Y. Kawaguchi, J. I. Inoue, Z. Matsuda: Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. In: Antimicrobial agents and chemotherapy. Band 60, Nummer 11, 11 2016, S. 6532–6539, doi:10.1128/AAC.01043-16, PMID 27550352, PMC 5075056.
  • J. M. Lucas, C. Heinlein, T. Kim, S. A. Hernandez, M. S. Malik, L. D. True, C. Morrissey, E. Corey, B. Montgomery, E. Mostaghel, N. Clegg, I. Coleman, C. M. Brown, E. L. Schneider, C. Craik, J. A. Simon, A. Bedalov, P. S. Nelson: The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. In: Cancer discovery. Band 4, Nummer 11, November 2014, S. 1310–1325, doi:10.1158/2159-8290.CD-13-1010, PMID 25122198, PMC 4409786.
  • M. Yamamoto, S. Matsuyama, X. Li, M. Takeda, Y. Kawaguchi, J. I. Inoue, Z. Matsuda: Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. In: Antimicrobial agents and chemotherapy. Band 60, Nummer 11, 11 2016, S. 6532–6539, doi:10.1128/AAC.01043-16, PMID 27550352, PMC 5075056.
  • E. Böttcher, C. Freuer, T. Steinmetzer, H. D. Klenk, W. Garten: MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. In: Vaccine. Band 27, Nummer 45, Oktober 2009, S. 6324–6329, doi:10.1016/j.vaccine.2009.03.029, PMID 19840668.
  • G. Simmons, S. Bertram, I. Glowacka, I. Steffen, C. Chaipan, J. Agudelo, K. Lu, A. J. Rennekamp, H. Hofmann, P. Bates, S. Pöhlmann: Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion. In: Virology. Band 413, Nummer 2, Mai 2011, S. 265–274, doi:10.1016/j.virol.2011.02.020, PMID 21435673, PMC 3086175.
  • E. Böttcher, C. Freuer, T. Steinmetzer, H. D. Klenk, W. Garten: MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. In: Vaccine. Band 27, Nummer 45, Oktober 2009, S. 6324–6329, doi:10.1016/j.vaccine.2009.03.029, PMID 19840668.
  • D. Meyer, F. Sielaff, M. Hammami, E. Böttcher-Friebertshäuser, W. Garten, T. Steinmetzer: Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation. In: The Biochemical journal. Band 452, Nummer 2, Juni 2013, S. 331–343, doi:10.1042/BJ20130101, PMID 23527573.
  • E. Böttcher-Friebertshäuser, C. Freuer, F. Sielaff, S. Schmidt, M. Eickmann, J. Uhlendorff, T. Steinmetzer, H. D. Klenk, W. Garten: Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. In: Journal of Virology. Band 84, Nummer 11, Juni 2010, S. 5605–5614, doi:10.1128/JVI.00140-10, PMID 20237084, PMC 2876594.
  • Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N (2001년 1월 22일). 《TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection》. doi:10.1128/JVI.01815-18.
  • Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S. Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche, Marcel A. Müller, Christian Drosten,Stefan Pöhlmann: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell (2020), doi:10.1016/j.cell.2020.02.052

ensembl.org (Global: 630th place; Korean: 323rd place)

may2017.archive.ensembl.org

nih.gov (Global: 5th place; Korean: 4th place)

ncbi.nlm.nih.gov

  • “Human PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
  • “Mouse PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
  • A. Shulla, T. Heald-Sargent, G. Subramanya, J. Zhao, S. Perlman, T. Gallagher: A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. In: Journal of Virology. Band 85, Nummer 2, Januar 2011, S. 873–882, doi:10.1128/JVI.02062-10, PMID 21068237, PMC 3020023.
  • Shirato K, Kanou K, Kawase M, Matsuyama S.: "Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry." In: J Virol. Dec 2016, doi:10.1128/JVI.01387-16, PMID 27733646 .
  • A. Zumla, J. F. Chan, E. I. Azhar, D. S. Hui, K. Y. Yuen: Coronaviruses - drug discovery and therapeutic options. In: Nature reviews. Drug discovery. Band 15, Nummer 5, 05 2016, S. 327–347, doi:10.1038/nrd.2015.37, PMID 26868298 (Review).
  • J. K. Sai, M. Suyama, Y. Kubokawa, Y. Matsumura, K. Inami, S. Watanabe: Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease. In: Journal of gastroenterology. Band 45, Nummer 3, März 2010, S. 335–341, doi:10.1007/s00535-009-0148-1, PMID 19876587.
  • R. Talukdar, R. K. Tandon: Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. In: Journal of gastroenterology and hepatology. Band 23, Nummer 1, Januar 2008, S. 34–41, doi:10.1111/j.1440-1746.2007.05206.x, PMID 17995943 (Review).
  • A. V. Ovcharenko, O. P. Zhirnov: Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. In: Antiviral research. Band 23, Nummer 2, Februar 1994, S. 107–118, doi:10.1016/0166-3542(94)90038-8, PMID 7511880.
  • A. Shulla, T. Heald-Sargent, G. Subramanya, J. Zhao, S. Perlman, T. Gallagher: A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. In: Journal of Virology. Band 85, Nummer 2, Januar 2011, S. 873–882, doi:10.1128/JVI.02062-10, PMID 21068237, PMC 3020023.
  • M. Yamamoto, S. Matsuyama, X. Li, M. Takeda, Y. Kawaguchi, J. I. Inoue, Z. Matsuda: Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. In: Antimicrobial agents and chemotherapy. Band 60, Nummer 11, 11 2016, S. 6532–6539, doi:10.1128/AAC.01043-16, PMID 27550352, PMC 5075056.
  • J. M. Lucas, C. Heinlein, T. Kim, S. A. Hernandez, M. S. Malik, L. D. True, C. Morrissey, E. Corey, B. Montgomery, E. Mostaghel, N. Clegg, I. Coleman, C. M. Brown, E. L. Schneider, C. Craik, J. A. Simon, A. Bedalov, P. S. Nelson: The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. In: Cancer discovery. Band 4, Nummer 11, November 2014, S. 1310–1325, doi:10.1158/2159-8290.CD-13-1010, PMID 25122198, PMC 4409786.
  • M. Yamamoto, S. Matsuyama, X. Li, M. Takeda, Y. Kawaguchi, J. I. Inoue, Z. Matsuda: Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. In: Antimicrobial agents and chemotherapy. Band 60, Nummer 11, 11 2016, S. 6532–6539, doi:10.1128/AAC.01043-16, PMID 27550352, PMC 5075056.
  • E. Böttcher, C. Freuer, T. Steinmetzer, H. D. Klenk, W. Garten: MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. In: Vaccine. Band 27, Nummer 45, Oktober 2009, S. 6324–6329, doi:10.1016/j.vaccine.2009.03.029, PMID 19840668.
  • G. Simmons, S. Bertram, I. Glowacka, I. Steffen, C. Chaipan, J. Agudelo, K. Lu, A. J. Rennekamp, H. Hofmann, P. Bates, S. Pöhlmann: Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion. In: Virology. Band 413, Nummer 2, Mai 2011, S. 265–274, doi:10.1016/j.virol.2011.02.020, PMID 21435673, PMC 3086175.
  • E. Böttcher, C. Freuer, T. Steinmetzer, H. D. Klenk, W. Garten: MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. In: Vaccine. Band 27, Nummer 45, Oktober 2009, S. 6324–6329, doi:10.1016/j.vaccine.2009.03.029, PMID 19840668.
  • D. Meyer, F. Sielaff, M. Hammami, E. Böttcher-Friebertshäuser, W. Garten, T. Steinmetzer: Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation. In: The Biochemical journal. Band 452, Nummer 2, Juni 2013, S. 331–343, doi:10.1042/BJ20130101, PMID 23527573.
  • E. Böttcher-Friebertshäuser, C. Freuer, F. Sielaff, S. Schmidt, M. Eickmann, J. Uhlendorff, T. Steinmetzer, H. D. Klenk, W. Garten: Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. In: Journal of Virology. Band 84, Nummer 11, Juni 2010, S. 5605–5614, doi:10.1128/JVI.00140-10, PMID 20237084, PMC 2876594.